Etomidate’s temporary listing as Class C drug in Singapore extended to April 30
SINGAPORE – The temporary listing of etomidate as a Class C drug has been extended till April 30.…
Senate Leaders Warn Hegseth About Procuring Generic Drugs Overseas — ProPublica
Senate leaders are urging the Department of Defense to prioritize the purchase of generic drugs manufactured in the…
Ozempic, Wegovy list prices to be slashed by up to 50%
Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50%…
New GLP-1 pill helps patients lose up to 8% of body weight, trial shows | Weight-loss drugs
A new daily pill could be a more effective GLP-1 tablet for weight loss, according to a clinical…
Acid reflux sufferers urged to avoid major ‘error’ when taking medication
People who are battling uncomfortable acid reflux symptoms with medication have been urged to be cautious about one…
Medication shortage hits UK as statins and aspirin ‘disappear from shelves’
A pharmacist has warned people the UK has been hit with a medication shortage. Even popular medicines like…
Anyone taking tablets issued warning over making ‘dangerous’ mistake
People who take medication are being urged to avoid making a major error which could have harmful consequences…
Scientists discover tribal medicine for dogs in N. Ecija as distinct plant species
A plant long used by the indigenous Bugkalot folk of Nueva Ecija to treat ailing dogs has now…
Breakthrough method gives ‘snapshot’ of a plant’s metabolic effects
Scientists developed a new way to help understand what happens in the body when people consume a plant…
GLP-1 Medications for Weight Loss: How to Get Started | News
Any licensed health care provider—including primary care physicians, nurse practitioners, physician assistants, and specialists such as endocrinologists, cardiologists,…
Can GLP-1 Weight Loss Drugs Cause Scurvy? What to Know
Share on PinterestReports of people developing scurvy while taking GLP-1 medications are on the rise. Milles Team/ShutterstockReports of…
1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market Crash
Although pegged as a weight-loss stock, this drug maker’s core business has long been diabetes. Novo Nordisk (NVO…